Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. 8-K Event Bylaws or fiscal year change · Shareholder vote results · Other events
  2. 8-K Event Other events
  3. 8-K Event Delisting notice · Executive or director change · Other events
  4. 8-K Event Other events
  5. 8-K Event Other events
  6. 8-K Event Other events
  7. 8-K Event Other events
  8. 8-K Event Delisting notice
  9. 8-K Event Material agreement · Other events
  10. 8-K Event Other events
  11. 8-K Event Delisting notice
  12. 8-K Event Other events
  13. 8-K Event Executive or director change · Shareholder vote results
  14. 8-K Event Bylaws or fiscal year change
  15. 8-K Event Agreement ended
  16. 8-K Event Material agreement · New debt or obligation
  17. 8-K Event Other events
  18. 8-K Event Material agreement
  19. 8-K Event Material agreement · Unregistered share sale
  20. 8-K Event Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure

Page 1 of 14 · 269 filings